Auranofin
(IRPYFWIZKIOHQN-XTZHGVARSA-N)
Structure
- SMILES
- CC(=O)OC[C@H]1O[C@@H]([S-])[C@@H]([C@H]([C@@H]1OC(=O)C)OC(=O)C)OC(=O)C.CC[PH+](CC)CC.[Au]
- Type(s)
- Approved; Investigational
- ATC code(s)
- M01CB03
- Molecular Formula:
- C20H35AuO9PS
- Molecular Weight:
- 679.492
- Log P:
- 1.8742
- Hydrogen Bond Acceptor:
- 10
- Hydrogen Bond Donor:
- 1
- TPSA:
- 128.02
- CAS Number(s):
- 34031-32-8
Synonym(s)
1.
Auranofin
2.
Crisinor
3.
Ridaura
4.
Ridauran
5.
SK&F D 39162
6.
SK&F-39162
7.
SK&F 39162
8.
SK&F39162
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rheumatoid Arthritis | FAERS: 2 | US FAERS | |
| 2 | Bunion operation | FAERS: 1 | US FAERS | |
| 3 | Drug ineffective | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Fatigue | FAERS: 1 | US FAERS | |
| 5 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 6 | Osteopenia | FAERS: 1 | US FAERS | |
| 7 | Pain | FAERS: 1 | US FAERS | |
| 8 | Unevaluable event | FAERS: 1 | US FAERS | |
| 9 | Vitamin D Deficiency | FAERS: 1 | US FAERS | |
| 10 | Leukopenia | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.